The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for the TrialNet Coordinating Center (TNCC), which is part of the TrialNet network. The TNCC plays a crucial role in identifying individuals with type 1 diabetes (T1D) at different stages of the disease and enrolling them in trials and studies aimed at preventing the progression of clinical symptoms and preserving insulin production. The TNCC supports various research projects, manages data and samples, and oversees network administration and operations. The TNCC will also be responsible for evaluating, selecting, and funding Clinical Centers and central support units necessary for TrialNet's clinical studies. The TNCC PD/PI will be a voting member of the TrialNet Executive and Steering Committees. The funding opportunity announcement is expected to be published in Spring 2024, with an application due date in Summer 2024. The TNCC will be funded through a cooperative agreement, and the estimated total program funding is $29,500,000.